Middle East respiratory syndrome coronavirus nonstructural protein 16 is necessary for interferon resistance and viral pathogenesis

mSphere

Volumn 2, Issue 6, 2017, Pages

  Menachery, Vineet D ^a,b   Gralinski, Lisa E ^b   Mitchell, Hugh D ^d   Dinnon, Kenneth H ^b   Leist, Sarah R ^b   Yount, Boyd L ^b   Graham, Rachel L ^b   McAnarney, Eileen T ^a,b   Stratton, Kelly G ^d   Cockrell, Adam S ^b   Debbink, Kari ^e   Sims, Amy C ^b   Waters, Katrina M ^d   Baric, Ralph S ^b,c  

^a University of Texas Medical Branch School of Medicine   (United States)

^b IL   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^e BOWIE STATE UNIVERSITY   (United States)

Author keywords

Coronavirus; Emerging virus; IFIT; Live attenuated; MERS CoV; Methyltransferase; SARS CoV; Vaccine

Indexed keywords

EID: 85041525335     PISSN: None     EISSN: 23795042     Source Type: Journal    
DOI: 10.1128/mSphere.00346-17     Document Type: Article

References (38)

1. Vijay R, Perlman S. 2016. Middle East respiratory syndrome and severe acute respiratory syndrome. Curr Opin Virol 16:70-76. https://doi.org/ 10.1016/j.coviro.2016.01.011
2. Zumla A, Hui DS, Perlman S. 2015. Middle East respiratory syndrome. Lancet 386:995-1007. https://doi.org/10.1016/S0140-6736(15)60454-8
3. Okba NM, Raj VS, Haagmans BL. 2017. Middle East respiratory syndrome coronavirus vaccines: current status and novel approaches. Curr Opin Virol 23:49-58. https://doi.org/10.1016/j.coviro.2017.03.007
4. Majumder MS, Kluberg SA, Mekaru SR, Brownstein JS. 2015. Mortality risk factors for Middle East respiratory syndrome outbreak, South Korea, 2015. Emerg Infect Dis 21:2088-2090. https://doi.org/10.3201/eid2111. 151231
5. Menachery VD, Graham RL, Baric RS. 2017. Jumping species-a mechanism for coronavirus persistence and survival. Curr Opin Virol 23:1-7. https://doi.org/10.1016/j.coviro.2017.01.002
6. Totura AL, Baric RS. 2012. SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon. Curr Opin Virol 2:264-275. https://doi.org/10.1016/j.coviro.2012.04.004
7. Snijder EJ, Decroly E, Ziebuhr J. 2016. The nonstructural proteins directing coronavirus RNA synthesis and processing. Adv Virus Res 96:59-126. https://doi.org/10.1016/bs.aivir.2016.08.008
8. Menachery VD, Debbink K, Baric RS. 2014. Coronavirus non-structural protein 16: evasion, attenuation, and possible treatments. Virus Res 194:191-199. https://doi.org/10.1016/j.virusres.2014.09.009
9. Züst R, Cervantes-Barragan L, Habjan M, Maier R, Neuman BW, Ziebuhr J, Szretter KJ, Baker SC, Barchet W, Diamond MS, Siddell SG, Ludewig B, Thiel V. 2011. Ribose 2=-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. Nat Immunol 12:137-143. https://doi.org/10.1038/ni.1979
10. Menachery VD, Yount BL, Jr., Josset L, Gralinski LE, Scobey T, Agnihothram S, Katze MG, Baric RS. 2014. Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2=-O-methyltransferase activity. J Virol 88:4251-4264. https://doi.org/10.1128/JVI. 03571-13
11. Decroly E, Imbert I, Coutard B, Bouvet M, Selisko B, Alvarez K, Gorbalenya AE, Snijder EJ, Canard B. 2008. Coronavirus nonstructural protein 16 is a cap-0 binding enzyme possessing (nucleoside-2=O)-methyltransferase activity. J Virol 82:8071-8084. https://doi.org/10.1128/JVI.00407-08
12. Egloff MP, Benarroch D, Selisko B, Romette JL, Canard B. 2002. An RNA cap (nucleoside-2=-O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization. EMBO J 21: 2757-2768. https://doi.org/10.1093/emboj/21.11.2757
13. Scobey T, Yount BL, Sims AC, Donaldson EF, Agnihothram SS, Menachery VD, Graham RL, Swanstrom J, Bove PF, Kim JD, Grego S, Randell SH, Baric RS. 2013. Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus. Proc Natl Acad Sci U S A 110:16157-16162. https://doi.org/10.1073/pnas.1311542110
14. Corti D, Zhao J, Pedotti M, Simonelli L, Agnihothram S, Fett C, Fernandez-Rodriguez B, Foglierini M, Agatic G, Vanzetta F, Gopal R, Langrish CJ, Barrett NA, Sallusto F, Baric RS, Varani L, Zambon M, Perlman S, Lanzavecchia A. 2015. Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus. Proc Natl Acad Sci U S A 112:10473-10478. https://doi.org/10.1073/pnas. 1510199112
15. Cockrell A, Yount BL, Scobey T, Jensen K, Douglas M, Beall A, Tang X-C, Marasco WA, Heise MT, Baric RS. 2016. A mouse model for MERS coronavirus induced acute respiratory distress syndrome. Nat Microbiol 2:16226. https://doi.org/10.1038/nmicrobiol.2016.226
16. Deng X, Hackbart M, Mettelman RC, O'Brien A, Mielech AM, Yi G, Kao CC, Baker SC. 2017. Coronavirus nonstructural protein 15 mediates evasion of dsRNA sensors and limits apoptosis in macrophages. Proc Natl Acad Sci U S A 114:E4251-E4260. https://doi.org/10.1073/pnas.1618310114
17. Lim SP, Noble CG, Shi PY. 2015. The dengue virus NS5 protein as a target for drug discovery. Antiviral Res 119:57-67. https://doi.org/10.1016/j. antiviral.2015.04.010
18. Caillet-Saguy C, Lim SP, Shi PY, Lescar J, Bressanelli S. 2014. Polymerases of hepatitis C viruses and flaviviruses: structural and mechanistic insights and drug development. Antiviral Res 105:8-16. https://doi.org/10.1016/ j.antiviral.2014.02.006
19. Chang DC, Hoang LT, Mohamed Naim AN, Dong H, Schreiber MJ, Hibberd ML, Tan MJA, Shi PY. 2016. Evasion of early innate immune response by 2=-O-methylation of dengue genomic RNA. Virology 499: 259-266. https://doi.org/10.1016/j.virol.2016.09.022
20. Dong H, Chang DC, Hua MH, Lim SP, Chionh YH, Hia F, Lee YH, Kukkaro P, Lok SM, Dedon PC, Shi PY. 2012. 2=-O methylation of internal adenosine by flavivirus NS5 methyltransferase. PLoS Pathog 8:e1002642. https://doi.org/10.1371/journal.ppat.1002642
21. Zhao Y, Soh TS, Zheng J, Chan KW, Phoo WW, Lee CC, Tay MY, Swaminathan K, Cornvik TC, Lim SP, Shi PY, Lescar J, Vasudevan SG, Luo D. 2015. A crystal structure of the dengue virus NS5 protein reveals a novel inter-domain interface essential for protein flexibility and virus replication. PLoS Pathog 11:e1004682. https://doi.org/10.1371/journal.ppat. 1004682
22. Graham RL, Becker MM, Eckerle LD, Bolles M, Denison MR, Baric RS. 2012. A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease. Nat Med 18:1820-1826. https://doi.org/10.1038/nm.2972
23. Eckerle LD, Becker MM, Halpin RA, Li K, Venter E, Lu X, Scherbakova S, Graham RL, Baric RS, Stockwell TB, Spiro DJ, Denison MR. 2010. Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing. PLoS Pathog 6:e1000896. https://doi. org/10.1371/journal.ppat.1000896
24. Smith EC, Blanc H, Surdel MC, Vignuzzi M, Denison MR. 2013. Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics. PLoS Pathog 9:e1003565. https://doi.org/10.1371/journal.ppat.1003565
25. Lamirande EW, DeDiego ML, Roberts A, Jackson JP, Alvarez E, Sheahan T, Shieh WJ, Zaki SR, Baric R, Enjuanes L, Subbarao K. 2008. A live attenuated severe acute respiratory syndrome coronavirus is immunogenic and efficacious in golden Syrian hamsters. J Virol 82:7721-7724. https://doi.org/10.1128/JVI.00304-08
26. Netland J, DeDiego ML, Zhao J, Fett C, Alvarez E, Nieto-Torres JL, Enjuanes L, Perlman S. 2010. Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease. Virology 399:120-128. https://doi.org/ 10.1016/j.virol.2010.01.004
27. Becares M, Pascual-Iglesias A, Nogales A, Sola I, Enjuanes L, Zuñiga S. 2016. Mutagenesis of coronavirus nsp14 reveals its potential role in modulation of the innate immune response. J Virol 90:5399-5414. https://doi.org/10.1128/JVI.03259-15
28. Almazán F, DeDiego ML, Sola I, Zuñiga S, Nieto-Torres JL, Marquez-Jurado S, Andrés G, Enjuanes L. 2013. Engineering a replicationcompetent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate. mBio 4:e00650-13. https://doi.org/ 10.1128/mBio.00650-13
29. Ortego J, Escors D, Laude H, Enjuanes L. 2002. Generation of a replication-competent, propagation-deficient virus vector based on the transmissible gastroenteritis coronavirus genome. J Virol 76: 11518-11529. https://doi.org/10.1128/JVI.76.22.11518-11529.2002
30. Fischer F, Stegen CF, Masters PS, Samsonoff WA. 1998. Analysis of constructed E gene mutants of mouse hepatitis virus confirms a pivotal role for E protein in coronavirus assembly. J Virol 72:7885-7894
31. Bolles M, Deming D, Long K, Agnihothram S, Whitmore A, Ferris M, Funkhouser W, Gralinski L, Totura A, Heise M, Baric RS. 2011. A doubleinactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge. J Virol 85: 12201-12215. https://doi.org/10.1128/JVI.06048-11
32. Menachery VD, Yount BL, Jr., Debbink K, Agnihothram S, Gralinski LE, Plante JA, Graham RL, Scobey T, Ge XY, Donaldson EF, Randell SH, Lanzavecchia A, Marasco WA, Shi ZL, Baric RS. 2015. A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence. Nat Med 21:1508-1513. https://doi.org/10.1038/nm.3985
33. Menachery VD, Yount BL, Jr., Sims AC, Debbink K, Agnihothram SS, Gralinski LE, Graham RL, Scobey T, Plante JA, Royal SR, Swanstrom J, Sheahan TP, Pickles RJ, Corti D, Randell SH, Lanzavecchia A, Marasco WA, Baric RS. 2016. SARS-like WIV1-CoV poised for human emergence. Proc Natl Acad Sci U S A 113:3048-3053. https://doi.org/10.1073/pnas. 1517719113
34. Sheahan T, Whitmore A, Long K, Ferris M, Rockx B, Funkhouser W, Donaldson E, Gralinski L, Collier M, Heise M, Davis N, Johnston R, Baric RS. 2011. Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus. J Virol 85:217-230. https://doi.org/10. 1128/JVI.01805-10
35. Jimenez-Guardeño JM, Regla-Nava JA, Nieto-Torres JL, DeDiego ML, Castaño-Rodriguez C, Fernandez-Delgado R, Perlman S, Enjuanes L. 2015. Identification of the mechanisms causing reversion to virulence in an attenuated SARS-CoV for the design of a genetically stable vaccine. PLoS Pathog 11:e1005215. https://doi.org/10.1371/journal.ppat.1005215
36. Li C, Bankhead A, III, Eisfeld AJ, Hatta Y, Jeng S, Chang JH, Aicher LD, Proll S, Ellis AL, Law GL, Waters KM, Neumann G, Katze MG, McWeeney S, Kawaoka Y. 2011. Host regulatory network response to infection with highly pathogenic H5N1 avian influenza virus. J Virol 85:10955-10967. https://doi.org/10.1128/JVI.05792-11
37. Sims AC, Tilton SC, Menachery VD, Gralinski LE, Schäfer A, Matzke MM, Webb-Robertson BJ, Chang J, Luna ML, Long CE, Shukla AK, Bankhead AR III, Burkett SE, Zornetzer G, Tseng CT, Metz TO, Pickles R, McWeeney S, Smith RD, Katze MG, Waters KM, Baric RS. 2013. Release of severe acute respiratory syndrome coronavirus nuclear import block enhances host transcription in human lung cells. J Virol 87:3885-3902. https://doi. org/10.1128/JVI.02520-12
38. Chen Y, Su C, Ke M, Jin X, Xu L, Zhang Z, Wu A, Sun Y, Yang Z, Tien P, Ahola T, Liang Y, Liu X, Guo G. 2011. Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2'-O-methylation by nsp16/nsp10 protein complex. PLoS Pathog 7:e1002294. https://doi. org/10.1371/journal.ppat.1002294